1	Thrombospondins	Thrombospondin	B-NP	NNS	B-protein	12	NMOD	0
2	,	,	O	,	O	12	P	0
3	metallo	metallo	B-NP	NN	B-protein	4	NMOD	0
4	proteases	protease	I-NP	NNS	I-protein	7	NMOD	0
5	and	and	O	CC	O	7	NMOD	0
6	thrombospondin	thrombospondin	B-NP	NN	B-RNA	7	NMOD	0
7	receptors	receptor	I-NP	NNS	I-RNA	12	NMOD	0
8	messenger	messenger	I-NP	NN	I-RNA	9	NMOD	0
9	RNA	RNA	I-NP	NN	I-RNA	12	NMOD	0
10	and	and	O	CC	O	12	NMOD	0
11	protein	protein	B-NP	NN	O	12	NMOD	0
12	expression	expression	I-NP	NN	O	0	ROOT	10	expression
13	in	in	B-PP	IN	O	12	NMOD	0
14	different	different	B-NP	JJ	O	16	NMOD	0
15	tumour	tumour	I-NP	NN	O	16	NMOD	0
16	sublines	subline	I-NP	NNS	O	13	PMOD	0
17	of	of	B-PP	IN	O	16	NMOD	0
18	the	the	B-NP	DT	O	22	NMOD	0
19	Dunning	Dunning	I-NP	JJ	O	22	NMOD	0
20	prostate	prostate	I-NP	NN	O	22	NMOD	0
21	cancer	cancer	I-NP	NN	O	22	NMOD	0
22	model	model	I-NP	NN	O	17	PMOD	0
23	.	.	O	.	O	12	P	0

1	Thrombospondin	Thrombospondin	B-NP	NN	B-protein	2	SUB	0
2	is	be	B-VP	VBZ	O	0	ROOT	0
3	a	a	B-NP	DT	O	5	NMOD	0
4	potent	potent	I-NP	JJ	O	5	NMOD	0
5	inhibitor	inhibitor	I-NP	NN	O	2	PRD	0
6	of	of	B-PP	IN	O	5	NMOD	0
7	angiogenesis	angiogenesis	B-NP	NN	O	6	PMOD	3	angiogenesis
8	and	and	O	CC	O	2	VMOD	0
9	might	might	B-VP	MD	O	2	VMOD	0
10	therefore	therefore	I-VP	RB	O	9	VMOD	0
11	be	be	I-VP	VB	O	9	VC	0
12	important	important	B-ADJP	JJ	O	11	PRD	0
13	in	in	B-PP	IN	O	12	AMOD	0
14	controlling	control	B-VP	VBG	O	13	PMOD	16	controlling
15	tumour	tumour	B-NP	NN	O	16	NMOD	0
16	growth	growth	I-NP	NN	O	14	OBJ	4	growth
17	.	.	O	.	O	2	P	0

1	TSP	TSP	B-NP	NN	B-protein	2	SUB	0
2	interacts	interact	B-VP	VBZ	O	0	ROOT	15	interacts
3	with	with	B-PP	IN	O	2	VMOD	0
4	a	a	B-NP	DT	O	5	NMOD	0
5	number	number	I-NP	NN	O	3	PMOD	0
6	of	of	B-PP	IN	O	5	NMOD	0
7	proteases	protease	B-NP	NNS	B-protein	9	NMOD	0
8	and	and	I-NP	CC	O	9	NMOD	0
9	receptors	receptor	I-NP	NNS	O	6	PMOD	0
10	and	and	B-PP	CC	O	3	PMOD	0
11	in	in	B-PP	IN	O	3	PMOD	0
12	this	this	B-NP	DT	O	13	NMOD	0
13	way	way	I-NP	NN	O	14	SUB	0
14	inhibits	inhibit	B-VP	VBZ	O	11	PMOD	18	inhibits
15	stimulation	stimulation	B-NP	NN	O	14	OBJ	17	stimulation
16	of	of	B-PP	IN	O	15	NMOD	0
17	angiogenesis	angiogenesis	B-NP	NN	O	16	PMOD	3	angiogenesis
18	.	.	O	.	O	2	P	0

1	An	An	B-NP	DT	O	3	NMOD	0
2	earlier	early	I-NP	JJR	O	3	NMOD	0
3	study	study	I-NP	NN	O	4	SUB	0
4	showed	show	B-VP	VBD	O	0	ROOT	0
5	that	that	B-SBAR	IN	O	4	VMOD	0
6	thrombospondin	thrombospondin	B-NP	NN	B-protein	7	SUB	0
7	is	be	B-VP	VBZ	O	5	SBAR	0
8	expressed	express	I-VP	VBN	O	7	VC	9	expressed
9	in	in	B-PP	IN	O	8	VMOD	0
10	benign	benign	B-NP	JJ	O	12	NMOD	0
11	prostatic	prostatic	I-NP	JJ	O	12	NMOD	0
12	hyperplasia	hyperplasia	I-NP	NN	O	20	NMOD	0
13	(	(	O	(	O	15	DEP	0
14	BPH	BPH	B-NP	NN	O	15	DEP	0
15	)	)	O	)	O	12	NMOD	0
16	and	and	O	CC	O	20	NMOD	0
17	high-grade	high-grade	B-NP	JJ	O	20	NMOD	0
18	prostatic	prostatic	I-NP	JJ	O	20	NMOD	0
19	intraepithelial	intraepithelial	I-NP	JJ	O	20	NMOD	0
20	neoplasia	neoplasia	I-NP	NN	O	9	PMOD	0
21	(	(	O	(	O	23	DEP	0
22	PIN	PIN	B-NP	NN	B-protein	23	DEP	0
23	)	)	O	)	O	20	NMOD	0
24	but	but	O	CC	O	7	VMOD	0
25	is	be	B-VP	VBZ	O	7	VMOD	0
26	absent	absent	B-ADJP	JJ	O	25	PRD	9	absent
27	in	in	B-PP	IN	O	26	AMOD	0
28	prostate	prostate	B-NP	NN	O	29	NMOD	0
29	cancer	cancer	I-NP	NN	O	27	PMOD	0
30	.	.	O	.	O	4	P	0

1	The	The	B-NP	DT	O	3	NMOD	0
2	present	present	I-NP	JJ	O	3	NMOD	0
3	study	study	I-NP	NN	O	4	SUB	0
4	was	be	B-VP	VBD	O	0	ROOT	0
5	therefore	therefore	I-VP	RB	O	4	VMOD	0
6	designed	design	I-VP	VBN	O	4	VC	0
7	to	to	I-VP	TO	O	8	VMOD	0
8	evaluate	evaluate	I-VP	VB	O	4	VMOD	0
9	the	the	B-NP	DT	O	10	NMOD	0
10	expression	expression	I-NP	NN	O	8	OBJ	9	expression
11	of	of	B-PP	IN	O	10	NMOD	0
12	thrombospondin	thrombospondin	B-NP	NN	B-protein	26	NMOD	0
13	1	1	I-NP	CD	I-protein	15	NMOD	0
14	and	and	I-NP	CC	I-protein	15	NMOD	0
15	2	2	I-NP	CD	I-protein	12	NMOD	0
16	(	(	O	(	O	20	DEP	0
17	TSP-1	TSP-1	B-NP	NN	B-protein	19	NMOD	0
18	,	,	O	,	O	19	P	0
19	TSP-2	TSP-2	B-NP	NN	B-protein	20	DEP	0
20	)	)	O	)	O	12	NMOD	0
21	,	,	O	,	O	26	P	0
22	TSP	TSP	B-NP	NN	B-protein	23	NMOD	0
23	receptors	receptor	I-NP	NNS	I-protein	26	NMOD	0
24	CD36	CD36	I-NP	NN	B-protein	26	NMOD	0
25	and	and	I-NP	CC	O	26	NMOD	0
26	CD47	CD47	I-NP	NN	B-protein	11	PMOD	0
27	,	,	O	,	O	26	P	0
28	and	and	O	CC	O	27	DEP	0
29	matrix-metalloproteases	matrix-metalloproteas	B-NP	NNS	B-protein	28	NMOD	0
30	2	2	B-NP	CD	I-protein	32	NMOD	0
31	and	and	I-NP	CC	I-protein	32	NMOD	0
32	9	9	I-NP	CD	I-protein	29	NMOD	0
33	(	(	O	(	O	37	DEP	0
34	MMP-	MMP-	B-NP	NN	O	36	NMOD	0
35	,	,	O	,	O	36	P	0
36	MMP-9	MMP-9	B-NP	NN	B-protein	37	DEP	0
37	)	)	O	)	O	29	NMOD	0
38	in	in	B-PP	IN	O	29	NMOD	0
39	a	a	B-NP	DT	O	43	NMOD	0
40	rat	rat	I-NP	NN	B-cell_line	43	NMOD	0
41	prostate	prostate	I-NP	NN	I-cell_line	43	NMOD	0
42	cancer	cancer	I-NP	NN	I-cell_line	43	NMOD	0
43	model	model	I-NP	NN	I-cell_line	38	PMOD	0
44	.	.	O	.	O	29	P	0

1	By	By	B-PP	IN	O	27	VMOD	0
2	using	use	B-VP	VBG	O	1	PMOD	0
3	immunohistochemistry	immunohistochemistry	B-NP	NN	O	10	NMOD	0
4	,	,	O	,	O	10	P	0
5	Western	Western	B-NP	NN	O	6	NMOD	0
6	blot	blot	I-NP	NN	O	10	NMOD	0
7	,	,	O	,	O	10	P	0
8	and	and	O	CC	O	10	NMOD	0
9	real-time	real-time	B-NP	JJ	O	10	NMOD	0
10	PCR	PCR	I-NP	NN	O	2	OBJ	0
11	the	the	B-NP	DT	O	13	NMOD	0
12	expression	expression	I-NP	NN	O	13	NMOD	9	expression
13	patterns	pattern	I-NP	NNS	O	27	SUB	0
14	of	of	B-PP	IN	O	13	NMOD	0
15	TSP-1	TSP-1	B-NP	NN	B-protein	26	NMOD	0
16	,	,	O	,	O	26	P	0
17	TSP-2	TSP-2	B-NP	NN	B-protein	26	NMOD	0
18	,	,	O	,	O	26	P	0
19	CD36	CD36	B-NP	NN	B-protein	26	NMOD	0
20	,	,	O	,	O	26	P	0
21	CD47	CD47	B-NP	NN	B-protein	26	NMOD	0
22	,	,	O	,	O	26	P	0
23	MMP-2	MMP-2	B-NP	NN	B-protein	26	NMOD	0
24	,	,	O	,	O	26	P	0
25	and	and	O	CC	O	26	NMOD	0
26	MMP-9	MMP-9	B-NP	NN	B-protein	14	PMOD	0
27	were	be	B-VP	VBD	O	0	ROOT	0
28	investigated	investigate	I-VP	VBN	O	27	VC	0
29	in	in	B-PP	IN	O	28	VMOD	0
30	normal	normal	B-NP	JJ	O	32	NMOD	0
31	rat	rat	I-NP	NN	O	32	NMOD	0
32	prostate	prostate	I-NP	NN	O	33	NMOD	0
33	tissue	tissue	I-NP	NN	O	38	NMOD	0
34	and	and	O	CC	O	38	NMOD	0
35	five	five	B-NP	CD	O	38	NMOD	0
36	malignant	malignant	I-NP	JJ	O	38	NMOD	0
37	Dunning	Dunning	I-NP	JJ	O	38	NMOD	0
38	sublines	subline	I-NP	NNS	O	39	NMOD	0
39	tissue	tissue	I-NP	NN	O	29	PMOD	0
40	.	.	O	.	O	27	P	0

1	TSP-1	TSP-1	B-NP	NN	B-RNA	3	NMOD	0
2	mRNA	mRNA	I-NP	NN	I-RNA	3	NMOD	0
3	levels	level	I-NP	NNS	O	4	SUB	0
4	were	be	B-VP	VBD	O	0	ROOT	0
5	decreased	decrease	I-VP	VBN	O	4	VC	18	decreased
6	in	in	B-PP	IN	O	5	VMOD	0
7	all	all	B-NP	DT	O	8	NMOD	0
8	tumours	tumour	I-NP	NNS	O	6	PMOD	0
9	compared	compare	B-PP	VBN	O	5	VMOD	0
10	with	with	B-PP	IN	O	9	PMOD	0
11	normal	normal	B-NP	JJ	O	12	NMOD	0
12	prostate	prostate	I-NP	NN	O	10	PMOD	0
13	.	.	O	.	O	4	P	0

1	However	However	B-ADVP	RB	O	4	VMOD	0
2	,	,	O	,	O	4	P	0
3	there	there	B-NP	EX	O	4	SUB	0
4	was	be	B-VP	VBD	O	0	ROOT	0
5	no	no	B-NP	DT	O	6	NMOD	0
6	difference	difference	I-NP	NN	O	4	PRD	0
7	in	in	B-PP	IN	O	6	NMOD	0
8	expression	expression	B-NP	NN	O	7	PMOD	10	expression
9	of	of	B-PP	IN	O	8	NMOD	0
10	TSP-2	TSP-2	B-NP	NN	B-protein	13	NMOD	0
11	and	and	O	CC	O	13	NMOD	0
12	CD36	CD36	B-NP	NN	B-RNA	13	NMOD	0
13	mRNA	mRNA	I-NP	NN	I-RNA	9	PMOD	0
14	in	in	B-PP	IN	O	8	NMOD	0
15	these	these	B-NP	DT	O	16	NMOD	0
16	samples	sample	I-NP	NNS	O	14	PMOD	0
17	.	.	O	.	O	4	P	0

1	MMP-2	MMP-2	B-NP	NN	B-protein	2	SUB	0
2	was	be	B-VP	VBD	O	12	VMOD	0
3	increased	increase	I-VP	VBN	O	2	VC	17	increased
4	with	with	B-PP	IN	O	3	VMOD	0
5	malignancy	malignancy	B-NP	NN	O	4	PMOD	0
6	,	,	O	,	O	12	P	0
7	but	but	O	CC	O	12	VMOD	0
8	no	no	B-NP	DT	O	9	NMOD	0
9	expression	expression	I-NP	NN	O	12	SUB	9	expression
10	of	of	B-PP	IN	O	9	NMOD	0
11	MMP-9	MMP-9	B-NP	NN	B-protein	10	PMOD	0
12	was	be	B-VP	VBD	O	0	ROOT	0
13	seen	see	I-VP	VBN	O	12	VC	0
14	.	.	O	.	O	12	P	0

1	The	The	B-NP	DT	O	3	NMOD	0
2	CD47	CD47	I-NP	NN	B-protein	3	NMOD	0
3	receptor	receptor	I-NP	NN	I-protein	4	SUB	0
4	did	do	B-VP	VBD	O	0	ROOT	0
5	slightly	slightly	I-VP	RB	O	4	VMOD	0
6	increase	increase	I-VP	VB	O	4	VC	17	increase
7	with	with	B-PP	IN	O	6	VMOD	0
8	malignancy	malignancy	B-NP	NN	O	7	PMOD	0
9	except	except	B-PP	IN	O	6	VMOD	0
10	for	for	B-PP	IN	O	9	PMOD	0
11	H3327	H3327	B-NP	NN	O	10	PMOD	0
12	.	.	O	.	O	4	P	0

1	The	The	B-NP	DT	O	2	NMOD	0
2	results	result	I-NP	NNS	O	3	SUB	0
3	showed	show	B-VP	VBD	O	0	ROOT	0
4	that	that	B-SBAR	IN	O	3	VMOD	0
5	thrombospondin	thrombospondin	B-NP	NN	B-protein	6	SUB	0
6	is	be	B-VP	VBZ	O	4	SBAR	0
7	expressed	express	I-VP	VBN	O	6	VC	9	expressed
8	in	in	B-PP	IN	O	7	VMOD	0
9	normal	normal	B-NP	JJ	O	10	NMOD	0
10	prostate	prostate	I-NP	NN	O	8	PMOD	0
11	but	but	B-PP	CC	O	8	PMOD	0
12	not	not	B-PP	RB	O	13	PMOD	0
13	in	in	I-PP	IN	O	8	PMOD	0
14	prostate	prostate	B-NP	NN	O	15	NMOD	0
15	tumours	tumour	I-NP	NNS	O	13	PMOD	0
16	in	in	B-PP	IN	O	15	NMOD	0
17	a	a	B-NP	DT	O	19	NMOD	0
18	rat	rat	I-NP	NN	O	19	NMOD	0
19	model	model	I-NP	NN	O	16	PMOD	0
20	.	.	O	.	O	3	P	0

1	Simultaneously	Simultaneously	B-ADVP	RB	O	5	VMOD	0
2	,	,	O	,	O	5	P	0
3	MMP-2	MMP-2	B-NP	NN	B-protein	4	NMOD	0
4	expression	expression	I-NP	NN	O	5	SUB	9	expression
5	increases	increase	B-VP	VBZ	O	0	ROOT	17	increases
6	with	with	B-PP	IN	O	5	VMOD	0
7	malignancy	malignancy	B-NP	NN	O	6	PMOD	0
8	.	.	O	.	O	5	P	0

